Synchrony Financial

  • Market Cap: Mid Cap
  • Industry: Finance
  • ISIN: US87165B1035
USD
80.40
1.25 (1.58%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Synchrony Financial stock-summary
stock-summary
Synchrony Financial
Finance
Synchrony Financial is a consumer financial services company. The Company provides a range of credit products through programs it has established with a group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations and healthcare service providers. The Company's revenue activities are managed through three sales platforms: Retail Card, Payment Solutions and CareCredit. It offers its credit products through its subsidiary, Synchrony Bank (the Bank). Through the Bank, it offers a range of deposit products insured by the Federal Deposit Insurance Corporation (FDIC), including certificates of deposit, individual retirement accounts (IRAs), money market accounts and savings accounts. The Company offers three types of credit products: credit cards, commercial credit products and consumer installment loans. The Company also offers a debt cancellation product. It offers two types of credit cards: private label credit cards and Dual Cards.
Company Coordinates stock-summary
Company Details
777 Long Ridge Rd , STAMFORD CT : 06902-1250
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 131 Schemes (42.53%)

Foreign Institutions

Held by 377 Foreign Institutions (24.26%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Richard Hartnack
Non-Executive Independent Chairman of the Board
Ms. Margaret Keane
Executive Chairman of the Board
Mr. P.W. Parker
Director
Mr. Fernando Aguirre
Independent Director
Mr. Paget Alves
Independent Director
Mr. Arthur Coviello
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
4,712 Million
(Quarterly Results - Jun 2025)
Net Profit:
967 Million
stock-summary
Industry

Finance

stock-summary
Market cap

USD 49,502 Million (Mid Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.18%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

19.39%

stock-summary
Price to Book

2.92